2022, Number 3
Argon plasma: therapeutic response and quality of life in patients with radiation proctitis
Language: Spanish
References: 31
Page: 1-8
PDF size: 1056.90 Kb.
ABSTRACT
Introduction: Chronic hemorrhagic radiation proctitis (CHRP) appears secondary to pelvic radiotherapy. Argon plasma coagulation (APC) is an effective, safe, easy-to-use, and relatively inexpensive therapy.Objective: To describe the short- and long-term therapeutic response of APC in patients with CHRP, as well as to evaluate the quality of life before and after the intervention.
Material and Methods: Observational, prospective case series study of 46 patients with CHRP, treated at the National Center for Minimally Access Surgery between 2017 and 2020. Summary measures and comparison of means (paired Student's t-test) were used for baseline and final hemoglobin, as well as for the quality of life scores applied before and after the intervention. The Kaplan-Meier method was used to determine the recurrence free time. A level of significance less than 0.05 was estimated for a 95 % confidence interval.
Results: A mean of 3,6 ± 2,394 APC sessions was required. The mean hemoglobin increased 1,9 g / L. Short-term therapeutic response was observed in 100 % of patients, and long-term in 91,3 %. The mean score for quality of life decreased by 12,065 points (p˂ 0,00). The perceived global perception increased by a mean of 7,326 points (p˂ 0,00).
Conclusions: APC has a good therapeutic response in the short and long term with few sessions and a low number of complications, with an improvement in the quality of life of the patients.
REFERENCES
Organización Mundial de la Salud. Estadísticas Sanitarias Mundiales 2020: monitoreando la salud para los ODS, objetivo de desarrollo sostenible [Internet]. Ginebra: Organización Mundial de la Salud; 2020 [Citado 04/11/2020]. Disponible en: Disponible en: https://apps.who.int/iris/Estadísticas-Sanitarias-Mundiales-2020 1.
Lee JK, Agrawal D, Thosani N, Al Haddad M, Buxbaum JL, Calderwood AH, et al3. . ASGE guideline on the role of endoscopy for bleeding from chronic radiation proctopathy. Gastrointest Endosc [Internet]. 2019 [Citado 01/01/2021];19:1-12. Disponible en: Disponible en: https://www.giejournal.org/article/S0016-5107(19)31661-X/fulltext 3.
Alpuim Costa D, Amaro CE, Nunes A, Cardoso JS, Daniel PM, Branco JV, et al. Hyperbaric oxygen therapy as a complementary treatment for radiation proctitis: Useless or useful? - A literature review. World J Gastroenterol [Internet]. 2021;27(27):4413-28. Disponible en: https://doi.org/10.3748/wjg.v27.i27.4413
Martínez López R, Díaz Canel Fernández O, Ruiz Torres J. Tratamiento de la proctitis actinica con argon plasma. Primera experiencia en Cuba. Rev haban cienc méd [Internet]. 2008 [Citado 04/11/2020];7(1):[Aprox. 2 p.]. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2008000100020 12.
Montes de Oca Megías E, Morera Pérez M, Pedroso Noa G. Endoscopic Therapy with Argon Plasma for Radiation Proctitis: Factors Associated to the Number of Therapeutic Sessions. Gastroenterol Hepatol Open Access [Internet]. 2017 [Citado 04/11/2020];8(2):00276. Disponible en: Disponible en: https://medcraveonline.com/GHOA/GHOA-08-00276.php 13.
Weiner J, Schwartz D, Martinez M. Long-term results on the efficacy of argon plasma coagulation for patients with chronic radiation proctopathy after conventionally fractionated, dose-escalated radiation therapy for prostate cancer. Pract Radiat Oncol [Internet]. 2017;7(1):e35-e42. Disponible en: https://doi.org/10.1016/j.prro.2016.07.009
Sebastian S, O'Connor H, O'Morain C. Argon plasma coagulation as first-line treatment for chronic radiation proctopathy. Journal of Gastroenterology and Hepatology [Internet]. 2004 [Citado 06/10/2020];19(10):1169-73. Disponible en: Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1440-1746.2004.03448.x 18.
Latorre Sánchez M, Sempere García-Argüelles J, Barceló Cerdá S. Valoración de la respuesta endoscópica al tratamiento con argón plasma en la rectitis actínica crónica. Rev Esp Enferm Dig [Internet]. 2008 [Citado 06/10/2020];100(10):619-24. Disponible en: Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082008001000004 21.
Hortelano E, Gómez Iturriaga A, Ortiz de Zarate R. Is argon plasma coagulation an elective and safe treatment option for patients with chronic radiation proctitis after high doses of radiotherapy?. Revista Española de Enfermedades Digestivas [Internet]. 2014 [Citado 06/10/2020];(3):165-70. Disponible en: Disponible en: http://www.grupoaran.com/mrmUpdate/lecturaPDFfromXML.asp?IdArt=4620880&TO=RVN&Eng=1 22.
Kwan V, Bourke MJ, Williams SJ, Gillespie PE, Murray MA, Kaffes AJ, et al. Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up. Am J Gastroenterol [Internet]. 2006;101:58-63. Disponible en: https://doi.org/10.1111/j.1572-0241.2006.00370.x
Tjandra JJ, Sengupta S. Argon plasma coagulation is an efective treatment for refractory hemorrhagic radiation proctitis. Diseases of the Colon & Rectum [Internet]. 2001 [Citado 06/10/2020];44(12):1759-65. Disponible en: Disponible en: https://pdfs.semanticscholar.org/8569/d26f14715aeec6fb8e587bfe07caa33843fd.pdf 26.
Spry N, Halkett G, Aoun S, Spry J, Yeoh E. Development of an EORTC module to assess the quality of life of patients with proctitis following pelvic radiotherapy for malignancy. International Journal of Radiation Oncology, Biology and Physics [Internet]. 2008;72(2):522-8. Disponible en: https://doi.org/10.1016/j.ijrobp.2007.12.062
Halkett GB, Wigley CA, Aoun SM, Portaluri M, Tramacere F, Livi L, et al. International validation of the EORTC QLQPRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study. Radiation Oncology [Internet]. 2018;13:162. Disponible en: https://doi.org/10.1186/s13014-018-1107-x